Annual CFF
-$59.30 M
-$103.31 M-234.71%
31 December 2023
Summary:
AnaptysBio annual cash flow from financing activities is currently -$59.30 million, with the most recent change of -$103.31 million (-234.71%) on 31 December 2023. During the last 3 years, it has fallen by -$58.42 million (-6645.96%). ANAB annual CFF is now -120.28% below its all-time high of $292.45 million, reached on 31 December 2017.ANAB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$71.23 M
+$29.34 M+70.04%
01 September 2024
Summary:
AnaptysBio quarterly cash flow from financing activities is currently $71.23 million, with the most recent change of +$29.34 million (+70.04%) on 01 September 2024. Over the past year, it has increased by +$74.30 million (+2418.68%). ANAB quarterly CFF is now -71.66% below its all-time high of $251.34 million, reached on 31 December 2021.ANAB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$94.33 M
+$74.30 M+371.03%
01 September 2024
Summary:
AnaptysBio TTM cash flow from financing activities is currently $94.33 million, with the most recent change of +$74.30 million (+371.03%) on 01 September 2024. Over the past year, it has increased by +$146.52 million (+280.74%). ANAB TTM CFF is now -78.42% below its all-time high of $437.12 million, reached on 30 September 2018.ANAB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANAB Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -234.7% | +2418.7% | +280.7% |
| 3 y3 years | -6646.0% | +10000.0% | +8569.9% |
| 5 y5 years | -126.5% | +5112.7% | +1739.3% |
ANAB Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -123.5% | at low | -71.7% | +289.6% | -67.8% | +259.1% |
| 5 y | 5 years | -123.5% | at low | -71.7% | +289.6% | -67.8% | +259.1% |
| alltime | all time | -120.3% | at low | -71.7% | +289.6% | -78.4% | +259.1% |
AnaptysBio Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $71.23 M(+70.0%) | $94.33 M(+371.0%) |
| June 2024 | - | $41.89 M(-407.3%) | $20.03 M(-156.6%) |
| Mar 2024 | - | -$13.63 M(+164.3%) | -$35.36 M(-40.4%) |
| Dec 2023 | -$59.30 M(-234.7%) | -$5.16 M(+67.9%) | -$59.30 M(+13.6%) |
| Sept 2023 | - | -$3.07 M(-77.2%) | -$52.19 M(+331.7%) |
| June 2023 | - | -$13.49 M(-64.1%) | -$12.09 M(-759.2%) |
| Mar 2023 | - | -$37.57 M(-2027.9%) | $1.83 M(-95.8%) |
| Dec 2022 | $44.02 M(-82.6%) | $1.95 M(-94.7%) | $44.02 M(-85.0%) |
| Sept 2022 | - | $37.03 M(+8471.1%) | $293.40 M(+14.3%) |
| June 2022 | - | $432.00 K(-90.6%) | $256.62 M(-0.0%) |
| Mar 2022 | - | $4.61 M(-98.2%) | $256.74 M(+1.8%) |
| Dec 2021 | $252.30 M(<-9900.0%) | $251.34 M(>+9900.0%) | $252.30 M(>+9900.0%) |
| Sept 2021 | - | $241.00 K(-56.5%) | $1.09 M(-2.0%) |
| June 2021 | - | $554.00 K(+231.7%) | $1.11 M(+77.0%) |
| Mar 2021 | - | $167.00 K(+32.5%) | $627.00 K(-171.3%) |
| Dec 2020 | -$879.00 K(-80.4%) | $126.00 K(-52.1%) | -$879.00 K(-21.2%) |
| Sept 2020 | - | $263.00 K(+270.4%) | -$1.12 M(-60.1%) |
| June 2020 | - | $71.00 K(-105.3%) | -$2.80 M(-38.2%) |
| Mar 2020 | - | -$1.34 M(+1106.3%) | -$4.53 M(+0.8%) |
| Dec 2019 | -$4.49 M | -$111.00 K(-92.2%) | -$4.49 M(-21.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$1.42 M(-14.4%) | -$5.75 M(-102.6%) |
| June 2019 | - | -$1.66 M(+27.6%) | $222.26 M(-0.5%) |
| Mar 2019 | - | -$1.30 M(-5.2%) | $223.45 M(+0.0%) |
| Dec 2018 | $223.36 M(-23.6%) | -$1.37 M(-100.6%) | $223.36 M(-48.9%) |
| Sept 2018 | - | $226.60 M(<-9900.0%) | $437.12 M(+107.3%) |
| June 2018 | - | -$477.00 K(-65.5%) | $210.83 M(+0.2%) |
| Mar 2018 | - | -$1.38 M(-100.7%) | $210.37 M(-28.1%) |
| Dec 2017 | $292.45 M(+3289.6%) | $212.39 M(>+9900.0%) | $292.45 M(+225.9%) |
| Sept 2017 | - | $300.00 K(-132.0%) | $89.73 M(+0.8%) |
| June 2017 | - | -$938.00 K(-101.2%) | $89.06 M(-0.6%) |
| Mar 2017 | - | $80.70 M(+734.7%) | $89.61 M(+938.6%) |
| Dec 2016 | $8.63 M(-78.1%) | $9.67 M(-2651.2%) | $8.63 M(-546.4%) |
| Sept 2016 | - | -$379.00 K(-2.1%) | -$1.93 M(-105.0%) |
| June 2016 | - | -$387.00 K(+40.7%) | $38.71 M(-1.0%) |
| Mar 2016 | - | -$275.00 K(-69.2%) | $39.09 M(-0.8%) |
| Dec 2015 | $39.40 M(+701.7%) | -$892.00 K(-102.2%) | $39.40 M(-2.2%) |
| Sept 2015 | - | $40.27 M(<-9900.0%) | $40.30 M(>+9900.0%) |
| June 2015 | - | -$14.00 K(-132.6%) | $29.00 K(-32.6%) |
| Mar 2015 | - | $43.00 K | $43.00 K |
| Dec 2014 | $4.92 M(+150.3%) | - | - |
| Dec 2013 | $1.96 M | - | - |
FAQ
- What is AnaptysBio annual cash flow from financing activities?
- What is the all time high annual CFF for AnaptysBio?
- What is AnaptysBio annual CFF year-on-year change?
- What is AnaptysBio quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for AnaptysBio?
- What is AnaptysBio quarterly CFF year-on-year change?
- What is AnaptysBio TTM cash flow from financing activities?
- What is the all time high TTM CFF for AnaptysBio?
- What is AnaptysBio TTM CFF year-on-year change?
What is AnaptysBio annual cash flow from financing activities?
The current annual CFF of ANAB is -$59.30 M
What is the all time high annual CFF for AnaptysBio?
AnaptysBio all-time high annual cash flow from financing activities is $292.45 M
What is AnaptysBio annual CFF year-on-year change?
Over the past year, ANAB annual cash flow from financing activities has changed by -$103.31 M (-234.71%)
What is AnaptysBio quarterly cash flow from financing activities?
The current quarterly CFF of ANAB is $71.23 M
What is the all time high quarterly CFF for AnaptysBio?
AnaptysBio all-time high quarterly cash flow from financing activities is $251.34 M
What is AnaptysBio quarterly CFF year-on-year change?
Over the past year, ANAB quarterly cash flow from financing activities has changed by +$74.30 M (+2418.68%)
What is AnaptysBio TTM cash flow from financing activities?
The current TTM CFF of ANAB is $94.33 M
What is the all time high TTM CFF for AnaptysBio?
AnaptysBio all-time high TTM cash flow from financing activities is $437.12 M
What is AnaptysBio TTM CFF year-on-year change?
Over the past year, ANAB TTM cash flow from financing activities has changed by +$146.52 M (+280.74%)